Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study.

Toren P, Margel D, Kulkarni G, Finelli A, Zlotta A, Fleshner N.

BMJ. 2013 Apr 15;346:f2109. doi: 10.1136/bmj.f2109.

PMID:
23587564
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Benign prostatic hyperplasia progression and its impact on treatment.

Djavan B, Waldert M, Ghawidel C, Marberger M.

Curr Opin Urol. 2004 Jan;14(1):45-50. Review.

PMID:
15091050
[PubMed - indexed for MEDLINE]
3.

A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.

Naslund MJ, Miner M.

Clin Ther. 2007 Jan;29(1):17-25. Review.

PMID:
17379044
[PubMed - indexed for MEDLINE]
4.

Dutasteride/tamsulosin: in benign prostatic hyperplasia.

Keating GM.

Drugs Aging. 2012 May 1;29(5):405-19. doi: 10.2165/11208920-000000000-00000. Review.

PMID:
22550968
[PubMed - indexed for MEDLINE]
5.

Dutasteride: a review of its use in the management of prostate disorders.

Keam SJ, Scott LJ.

Drugs. 2008;68(4):463-85. Review.

PMID:
18318566
[PubMed - indexed for MEDLINE]
6.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
[PubMed - indexed for MEDLINE]
7.

Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasia.

Pinto F, Racioppi M, Sacco E, Totaro A, Brescia A, Volpe A, Gardi M, Bassi PF.

Arch Ital Urol Androl. 2009 Mar;81(1):1-8. Review.

PMID:
19499750
[PubMed - indexed for MEDLINE]
8.

Dutasteride: a new 5-alpha reductase inhibitor for men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Brown CT, Nuttall MC.

Int J Clin Pract. 2003 Oct;57(8):705-9. Review.

PMID:
14627182
[PubMed - indexed for MEDLINE]
9.

The natural history of benign prostatic hyperplasia.

Fitzpatrick JM.

BJU Int. 2006 Apr;97 Suppl 2:3-6; discussion 21-2. Review.

PMID:
16507045
[PubMed - indexed for MEDLINE]
10.

Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia.

Fowler C, McAllister W, Plail R, Karim O, Yang Q.

Health Technol Assess. 2005 Feb;9(4):iii-iv, 1-30. Review.

PMID:
15698525
[PubMed - indexed for MEDLINE]
Free Article
11.

Dutasteride: a dual 5-alpha reductase inhibitor for the treatment of symptomatic benign prostatic hyperplasia.

Dolder CR.

Ann Pharmacother. 2006 Apr;40(4):658-65. Epub 2006 Mar 28. Review.

PMID:
16569804
[PubMed - indexed for MEDLINE]
12.

Dutasteride: a novel dual inhibitor of 5alpha-reductase for benign prostatic hyperplasia.

Djavan B, Milani S, Fong YK.

Expert Opin Pharmacother. 2005 Feb;6(2):311-7. Review. Erratum in: Expert Opin Pharmacother. 2005 Apr;6(4):681.

PMID:
15757426
[PubMed - indexed for MEDLINE]
13.

Prevention of benign prostatic hyperplasia disease.

Marks LS, Roehrborn CG, Andriole GL.

J Urol. 2006 Oct;176(4 Pt 1):1299-306. Review.

PMID:
16952616
[PubMed - indexed for MEDLINE]
14.

Finasteride for benign prostatic hyperplasia.

Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006015. doi: 10.1002/14651858.CD006015.pub3. Review.

PMID:
20927745
[PubMed - indexed for MEDLINE]
15.

Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia.

Andriole GL, Kirby R.

Eur Urol. 2003 Jul;44(1):82-8. Review.

PMID:
12814679
[PubMed - indexed for MEDLINE]
16.

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.

Bartsch G, Rittmaster RS, Klocker H.

World J Urol. 2002 Apr;19(6):413-25. Review.

PMID:
12022710
[PubMed - indexed for MEDLINE]
17.

A review of combination therapy in patients with benign prostatic hyperplasia.

McVary KT.

Clin Ther. 2007 Mar;29(3):387-98. Review.

PMID:
17577460
[PubMed - indexed for MEDLINE]
18.

Dutasteride for the treatment of benign prostatic hyperplasia.

Wu C, Kapoor A.

Expert Opin Pharmacother. 2013 Jul;14(10):1399-408. doi: 10.1517/14656566.2013.797965. Review.

PMID:
23750593
[PubMed - indexed for MEDLINE]
19.

Definition of at-risk patients: dynamic variables.

Emberton M.

BJU Int. 2006 Apr;97 Suppl 2:12-5; discussion 21-2. Review.

PMID:
16507047
[PubMed - indexed for MEDLINE]
20.

Cholesterol and benign prostate disease.

Freeman MR, Solomon KR.

Differentiation. 2011 Nov-Dec;82(4-5):244-52. doi: 10.1016/j.diff.2011.04.005. Epub 2011 Aug 20. Review.

PMID:
21862201
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk